secwatch.observer — SEC 8-K summary
======================================

Issuer:     TECOGEN INC. (TGEN)
CIK:        0001537435
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0001537435-22-000101
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tecogen Q2 2022 revenue up 4.4% to $6.4M but net loss of $856K vs profit in prior year
--------------------------------------------------------------------------------

- Net loss of $856K ($0.03 EPS loss) vs net income of $399K ($0.02 EPS) in Q2 2021 due to absence of CARES Act credits.
- Revenue $6.4M (+4.4% QoQ); H1 revenue $13.9M (+13.5% YoY) driven by 52% product revenue growth.
- Gross margin fell to 42.1% from 46.3% on higher material costs; Product margin dropped to 33% from 43.1%.
- Adjusted EBITDA negative $651K vs positive $567K in prior year quarter.
- CEO cites price increases expected to help H2 margins; Inflation Reduction Act ITC seen as positive for clean energy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537435/000153743522000101/0001537435-22-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537435/000153743522000101/tgen-20220811.htm
  HTML page:      https://secwatch.observer/filing/0001537435-22-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer